NLS

Many Ebola patients in Africa could be saved if they were infused with salts and fluids, said Professor Anders Perner of Copenhagen University Hospital, Rigshospitalet, in an article in the Lancet. “It has taken us too long to acknowledge that we could save a lot of lives in West Africa by very simple means,” says […]

Eating bilberries reduces the negative impact of a high-fat diet on the body, according to a study performed at the University of Eastern Finland. Bilberries were shown for the first time to lower both blood pressure and nutrition-derived inflammatory responses. Low-grade inflammation and elevated blood pressure are often associated with obesity-related diseases. The study focused on […]

A research team from Finland thinks it knows why about 800 people out of the more than 30 million who received GlaxoSmithKline’s Pandemrix developed narcolepsy. Comparing Pandemrix with Arepanrix, a vaccine used in Canada with the same adjuvant, the researchers found that Pandemrix had more of one structurally altered viral nucleoprotein–a disparity lead researcher Outi […]

Danish biotech company Acesion Pharma, which is actively developing therapeutic treatments for atrial fibrillation (AF), has raised 15.2 million DKK (2.5 million USD) in a new equity investment round. The round includes Boston-based Broadview Ventures as a new investor and current investor Novo Seeds. The company is working on a treatment to prevent the recurrence […]

Norway’s BerGenBio has finished up a $15 million round to push its lead Axl kinase inhibitor into new Phase I and Phase II studies for acute myeloid leukemia. BerGenBio is in the early stages of developing a pipeline of epithelial-mesenchymal transition (EMT) inhibitors, with three antibodies and a small molecule for triple negative breast cancer in the […]

Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba®(insulin degludec) in children and adolescents aged 1-17 years with diabetes. Once the European Commission approves the label expansion, physicians in the European Union will be able to prescribe Tresiba® to children with type […]